304 related articles for article (PubMed ID: 20534538)
1. Inhibitor of growth-4 promotes IkappaB promoter activation to suppress NF-kappaB signaling and innate immunity.
Coles AH; Gannon H; Cerny A; Kurt-Jones E; Jones SN
Proc Natl Acad Sci U S A; 2010 Jun; 107(25):11423-8. PubMed ID: 20534538
[TBL] [Abstract][Full Text] [Related]
2. The ING4 tumor suppressor attenuates NF-kappaB activity at the promoters of target genes.
Nozell S; Laver T; Moseley D; Nowoslawski L; De Vos M; Atkinson GP; Harrison K; Nabors LB; Benveniste EN
Mol Cell Biol; 2008 Nov; 28(21):6632-45. PubMed ID: 18779315
[TBL] [Abstract][Full Text] [Related]
3. ING4 alleviated lipopolysaccharide-induced inflammation by regulating the NF-κB pathway via a direct interaction with SIRT1.
Yang Y; Liu Y; He X; Yang F; Han S; Qin A; Wu G; Liu M; Li Z; Wang J; Yang X; Hu D
Immunol Cell Biol; 2020 Feb; 98(2):127-137. PubMed ID: 31811786
[TBL] [Abstract][Full Text] [Related]
4. Histone Deacetylase Inhibitor RGFP109 Overcomes Temozolomide Resistance by Blocking NF-κB-Dependent Transcription in Glioblastoma Cell Lines.
Li ZY; Li QZ; Chen L; Chen BD; Wang B; Zhang XJ; Li WP
Neurochem Res; 2016 Dec; 41(12):3192-3205. PubMed ID: 27632183
[TBL] [Abstract][Full Text] [Related]
5. Negative regulation of NF-κB by the ING4 tumor suppressor in breast cancer.
Byron SA; Min E; Thal TS; Hostetter G; Watanabe AT; Azorsa DO; Little TH; Tapia C; Kim S
PLoS One; 2012; 7(10):e46823. PubMed ID: 23056468
[TBL] [Abstract][Full Text] [Related]
6. ING4 induces G2/M cell cycle arrest and enhances the chemosensitivity to DNA-damage agents in HepG2 cells.
Zhang X; Xu LS; Wang ZQ; Wang KS; Li N; Cheng ZH; Huang SZ; Wei DZ; Han ZG
FEBS Lett; 2004 Jul; 570(1-3):7-12. PubMed ID: 15251430
[TBL] [Abstract][Full Text] [Related]
7. Inhibitor of growth 4 induces NFκB/p65 ubiquitin-dependent degradation.
Hou Y; Zhang Z; Xu Q; Wang H; Xu Y; Chen K
Oncogene; 2014 Apr; 33(15):1997-2003. PubMed ID: 23624912
[TBL] [Abstract][Full Text] [Related]
8. Inhibitor of growth-4 mediates chromatin modification and has a suppressive effect on tumorigenesis and innate immunity.
Mathema VB; Koh YS
Tumour Biol; 2012 Feb; 33(1):1-7. PubMed ID: 21971889
[TBL] [Abstract][Full Text] [Related]
9. Superoxide potentiates NF-kappaB activation and modulates endotoxin-induced cytokine production in alveolar macrophages.
Ndengele MM; Muscoli C; Wang ZQ; Doyle TM; Matuschak GM; Salvemini D
Shock; 2005 Feb; 23(2):186-93. PubMed ID: 15665736
[TBL] [Abstract][Full Text] [Related]
10. Tumor suppressor ING4 overexpression contributes to proliferation and invasion inhibition in gastric carcinoma by suppressing the NF-κB signaling pathway.
Li S; Fan T; Liu H; Chen J; Qin C; Ren X
Mol Biol Rep; 2013 Oct; 40(10):5723-32. PubMed ID: 24057236
[TBL] [Abstract][Full Text] [Related]
11. Duration of nuclear NF-kappaB action regulated by reversible acetylation.
Chen Lf ; Fischle W; Verdin E; Greene WC
Science; 2001 Aug; 293(5535):1653-7. PubMed ID: 11533489
[TBL] [Abstract][Full Text] [Related]
12. The inhibition of LPS-induced production of inflammatory cytokines by HSP70 involves inactivation of the NF-kappaB pathway but not the MAPK pathways.
Shi Y; Tu Z; Tang D; Zhang H; Liu M; Wang K; Calderwood SK; Xiao X
Shock; 2006 Sep; 26(3):277-84. PubMed ID: 16912653
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of chroman carboxamide on interleukin-6 expression in response to lipopolysaccharide by preventing nuclear factor-kappaB activation in macrophages.
Kim BH; Lee KH; Chung EY; Chang YS; Lee H; Lee CK; Min KR; Kim Y
Eur J Pharmacol; 2006 Aug; 543(1-3):158-65. PubMed ID: 16797005
[TBL] [Abstract][Full Text] [Related]
14. New molecular bridge between RelA/p65 and NF-κB target genes via histone acetyltransferase TIP60 cofactor.
Kim JW; Jang SM; Kim CH; An JH; Kang EJ; Choi KH
J Biol Chem; 2012 Mar; 287(10):7780-91. PubMed ID: 22249179
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase Cdelta activates RelA/p65 and nuclear factor-kappaB signaling in response to tumor necrosis factor-alpha.
Lu ZG; Liu H; Yamaguchi T; Miki Y; Yoshida K
Cancer Res; 2009 Jul; 69(14):5927-35. PubMed ID: 19549902
[TBL] [Abstract][Full Text] [Related]
16. Negative regulation of NF-kappaB signaling by PIAS1.
Liu B; Yang R; Wong KA; Getman C; Stein N; Teitell MA; Cheng G; Wu H; Shuai K
Mol Cell Biol; 2005 Feb; 25(3):1113-23. PubMed ID: 15657437
[TBL] [Abstract][Full Text] [Related]
17. Interactions between NF-κB and SP3 connect inflammatory signaling with reduced FGF-10 expression.
Carver BJ; Plosa EJ; Stinnett AM; Blackwell TS; Prince LS
J Biol Chem; 2013 May; 288(21):15318-25. PubMed ID: 23558680
[TBL] [Abstract][Full Text] [Related]
18. The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis.
Garkavtsev I; Kozin SV; Chernova O; Xu L; Winkler F; Brown E; Barnett GH; Jain RK
Nature; 2004 Mar; 428(6980):328-32. PubMed ID: 15029197
[TBL] [Abstract][Full Text] [Related]
19. Antagonizing binding of cell cycle and apoptosis regulatory protein 1 (CARP-1) to the NEMO/IKKγ protein enhances the anticancer effect of chemotherapy.
Venkatesh J; Sekhar SC; Cheriyan VT; Muthu M; Meister P; Levi E; Dzinic S; Gauld JW; Polin LA; Rishi AK
J Biol Chem; 2020 Mar; 295(11):3532-3552. PubMed ID: 32024692
[TBL] [Abstract][Full Text] [Related]
20. SCF(JFK) is a bona fide E3 ligase for ING4 and a potent promoter of the angiogenesis and metastasis of breast cancer.
Yan R; He L; Li Z; Han X; Liang J; Si W; Chen Z; Li L; Xie G; Li W; Wang P; Lei L; Zhang H; Pei F; Cao D; Sun L; Shang Y
Genes Dev; 2015 Mar; 29(6):672-85. PubMed ID: 25792601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
